Clinical Trials in the Category "Head and Neck Neoplasms"
Drug Intervention Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
| Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy |
Quynh-Thu Le |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
| BIBW 2992 in Head&Neck Cancer |
Dr. A. Dimitrios Colevas |
Head and Neck Cancer
Carcinoma, Squamous Cell | |
| Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer |
Dr. A. Dimitrios Colevas |
Neuroendocrine Tumors
Thyroid Cancer | |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
Harlan Pinto |
Head and Neck Cancer | |
| Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma |
Dr. A. Dimitrios Colevas |
Head and Neck Cancer | |
| Chemotherapy and Radiation Therapy With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer |
Quynh-Thu Le |
Head and Neck Cancer | |
Device Intervention Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
| Assessing the da Vinci® Robotic Surgical System for sugery of the upper aerodigestive tract |
Edward J. Damrose MD, FACS |
Hypopharyngeal Neoplasms
Laryngeal Neoplasms | |
Other Trials that are Recruiting
Trials not Recruiting
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |

